BIOMAT Database Logo BIOMAT Database Logo

Probing the molecular mechanism of action of the HIV-1 reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) using pre-steady-state kinetics. 2014

Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, United States.

The novel antiretroviral 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) is a potent nucleoside HIV-1 reverse transcriptase (RT) inhibitor (NRTI). Unlike other FDA-approved NRTIs, EFdA contains a 3'-hydroxyl. Pre-steady-state kinetics showed RT preferred incorporating EFdA-TP over native dATP. Moreover, RT slowly inserted nucleotides past an EFdA-terminated primer, resulting in delayed chain termination with unaffected fidelity. This is distinct from KP1212, another 3'-hydroxyl-containing RT inhibitor considered to promote viral lethal mutagenesis. New mechanistic features of RT inhibition by EFdA are revealed.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanisms.
August 2014, The Journal of biological chemistry,
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor.
December 2009, The Journal of biological chemistry,
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitor.
July 2018, Current opinion in HIV and AIDS,
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA).
August 2016, Proceedings of the National Academy of Sciences of the United States of America,
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
Enantioselective Synthesis of 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) via Enzymatic Desymmetrization.
February 2017, Organic letters,
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA)-Suppressed Humanized Mice.
March 2019, Viruses,
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4'-Ethynyl-2-fluoro-2'-deoxyadenosine).
October 2018, Journal of medicinal chemistry,
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.
February 2011, Cellular and molecular biology (Noisy-le-Grand, France),
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
Pre-steady state kinetic analysis of cyclobutyl derivatives of 2'-deoxyadenosine 5'-triphosphate as inhibitors of HIV-1 reverse transcriptase.
June 2012, Bioorganic & medicinal chemistry letters,
Yagmur Muftuoglu, and Christal D Sohl, and Andrea C Mislak, and Hiroaki Mitsuya, and Stefan G Sarafianos, and Karen S Anderson
Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.
September 2012, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!